ARTICLE | Company News
biOasis, Abbott deal
June 25, 2012 7:00 AM UTC
biOasis partnered with Abbott to evaluate biOasis' Transcend technology, which is a soluble p97 (melanotransferrin) carrier protein that transports therapeutics across the blood brain barrier (BBB) u...